Michaela A. Ihle
Kerpener Str. 62
Koeln, NW 50924, Germany
Koeln, NW 50924, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Pitfalls in Detecting MET Exon 14 Skipping Variants by DNA- and RNA-Based Next-Generation Sequencing Technologies in a Large Real-World Cohort and Results of the First Multinational External Quality Assessment Schemes.
Journal: The Journal of molecular diagnostics : JMD
Published: February 11, 2026
Pitfalls in Detecting MET Exon 14 Skipping Variants by DNA- and RNA-Based Next-Generation Sequencing Technologies in a Large Real-World Cohort and Results of the First Multinational External Quality Assessment Schemes.
Journal: The Journal of molecular diagnostics : JMD
Published: February 11, 2026
Molecular and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer Harboring KRAS G12V Mutations.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 17, 2025
BMP signaling promotes zebrafish heart regeneration via alleviation of replication stress.
Journal: Nature communications
Published: May 17, 2024
Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters.
Journal: Scientific reports
Published: January 11, 2024
MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 25, 2023
Overview of Molecular Detection Technologies for MET in Lung Cancer.
Journal: Cancers
Published: April 01, 2023
Biomarker MET in tumor pathology
Journal: Pathologie (Heidelberg, Germany)
Published: December 19, 2022
Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 03, 2022
Impact of the interplay between stemness features, p53 and pol iota on replication pathway choices.
Journal: Nucleic acids research
Published: January 18, 2021
Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 21, 2020
Last Updated: 09/26/2026